Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) (2019)
- Authors:
- Autor USP: BURDMANN, EMMANUEL DE ALMEIDA - FM
- Unidade: FM
- DOI: 10.1053/j.ajkd.2018.10.006
- Subjects: ANEMIA; ERITROPOIETINA; HEMODIÁLISE; DOENÇAS CARDIOVASCULARES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2019
- Source:
- Título: American journal of kidney diseases
- ISSN: 0272-6386
- Volume/Número/Paginação/Ano: v. 73, n. 3, p. 309-315, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAUSLAND, Finnian R. Mc et al. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). American journal of kidney diseases, v. 73, n. 3, p. 309-315, 2019Tradução . . Disponível em: https://doi.org/10.1053/j.ajkd.2018.10.006. Acesso em: 25 jan. 2026. -
APA
Causland, F. R. M., Claggett, B., Burdmann, E. de A., Chertow, G. M., Cooper, M. E., Eckardt, K. -U., et al. (2019). Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). American journal of kidney diseases, 73( 3), 309-315. doi:10.1053/j.ajkd.2018.10.006 -
NLM
Causland FRM, Claggett B, Burdmann E de A, Chertow GM, Cooper ME, Eckardt K-U, Ivanovich P, Levey AS, Lewis EF, Mcgill JB. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) [Internet]. American journal of kidney diseases. 2019 ; 73( 3): 309-315.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1053/j.ajkd.2018.10.006 -
Vancouver
Causland FRM, Claggett B, Burdmann E de A, Chertow GM, Cooper ME, Eckardt K-U, Ivanovich P, Levey AS, Lewis EF, Mcgill JB. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) [Internet]. American journal of kidney diseases. 2019 ; 73( 3): 309-315.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1053/j.ajkd.2018.10.006 - COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil
- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
- Acute Kidney Injury: Global Health Alert [Editorial]
- Assessment of kidney function in patients with cancer
- Medical students' and health professionals' knowledge regarding acute kidney injury: a cross-sectional study in the city of Sao Paulo, Brazil
- Censo de Diálise do Brasil de 2009
- Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats
- Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- Gerenciamento do estresse e meditação
- Peritoneal Dialysis in Acute Kidney Injury: Lessons Learned and Applied
Informações sobre o DOI: 10.1053/j.ajkd.2018.10.006 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
